A new multi-centre study in mice has explained the mechanism behind how excessive consumption of fructose can 'overwhelm' the gut and lead to fatty liver disease, revealing the importance of fructose consumption timing.
Oral supplementation of l-glutamine prevents the progression of non-alcoholic steatohepatitis (NASH), reports a recent study in the Journal of Nutrition.
Diet and lifestyle changes reduced liver fat and improved metabolic health in overweight patients with non-alcoholic fatty liver disease (NAFLD), reveals a new study in Nutrients.
A joint venture between microbiome-focused Enterome and Nestlé Health Science will focus on the discovery and commercialisation of innovative diagnostics for a variety of microbiome-related diseases.
Milk fortified with phytosterols not only helped lower low-density lipoprotein cholesterol (LDL-C) in rats with non-alcoholic fatty liver disease (NAFLD), but also decreased fatty liver build-up, a study found.
CoQ10 supplementation may partly improve chronic inflammation in people with metabolic disorders, but further studies with larger sample sizes and well-defined trials are needed, according to new meta-analysis.
New meta-analysis from China “provides substantial evidence” that n-3 polyunsaturated fatty acid (PUFA) supplementation, especially DHA, can play a positive role in the treatment of non-alcoholic fatty liver disease (NAFLD).
Consuming a palm tocotrienol complex is safe and well tolerated in people with metabolic syndrome, say results of a randomized, double-blind, cross-over and placebo-controlled clinical trial.
Adding broccoli to an unhealthy diet could help stave of obesity-related liver disease and cancer, say researchers backed by the US National Cancer Institute.
Delta- and gamma-tocotrienols may be more effective than alpha-tocotrienol and alpha-tocopherol in attenuating metabolic syndrome, suggests a recent study in diet-induced obese rats.
Sodium butyrate supplements may help protect against inflammation in the liver and the development of Western-diet induced non-alcoholic steatohepatitis (NASH), research in mice has found.
Research, focus and regulatory cunning will be needed if the nutraceutical industry is to tap into the relatively unexplored area of non-alcoholic fatty liver disease (NAFLD), says the consultancy firm behind a new dedicated clinical trial platform.
Vitamin E can significantly improve liver function in patients with non-alcoholic fatty liver diseases (NAFLD) including non-alcoholic steatohepatisis (NASH), a meta-analysis of five clinical trials.
Mistletoe may be more than the cue for a Christmas kiss, after researchers found that a compound extracted from the festive plant could help battle obesity-related liver disease.
A mixture of vitamin E tocotrienols and alpha-tocopherol may work synergistically to improve liver health in lab animals with non-alcoholic steatohepatits (NASH), the most extreme form of non-alcoholic fatty liver disease (NAFLD).
A daily supplements of vitamin E was found to improve the health of the livers of people with non-alcoholic steatohepatitis (NASH), a liver disease, says a new study.
Dietary intakes of capsaicin, the compound that gives red pepper its heat, may prevent the development of diabetes-like symptoms in obese people, says a new study with mice.
Resveratrol, a polyphenol found in red wine, may prevent against the development of fatty liver disease associated with chronic alcohol consumption, according to a new study.
Extracts from green tea may stop the build-up of fatty deposits in
the liver, and offer benefits for this silent killer linked to
obesity, suggests a new study with mice.